Published by Josh White on 20th January 2023
(Sharecast News) - Commercial biotechnology company Allergy Therapeutics said in an update on Friday that it expects first-half revenue of £39.9m, making for a decrease of 18% year-on-year.
URL: http://www.digitallook.com/dl/news/story/33250284/...